MX2010003886A - Metodo para producir nucleosidos. - Google Patents
Metodo para producir nucleosidos.Info
- Publication number
- MX2010003886A MX2010003886A MX2010003886A MX2010003886A MX2010003886A MX 2010003886 A MX2010003886 A MX 2010003886A MX 2010003886 A MX2010003886 A MX 2010003886A MX 2010003886 A MX2010003886 A MX 2010003886A MX 2010003886 A MX2010003886 A MX 2010003886A
- Authority
- MX
- Mexico
- Prior art keywords
- derivative
- compound
- salts
- catalyst
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/12—Triazine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Saccharide Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Un m?todo para producir un compuesto de nucle?sido libre, excluyendo el compuesto 2'-desoxi-5-azacitidina (Decitabina), al hacer reaccionar un donador de gluc?sido, de preferencia un derivado de 1-hal?geno, o 1-O-arilo, 1-O-alquilo, o un imidato, de preferencia un derivado de triclorometilo, o un derivado de tioalquilo de un monosac?rido u oligosac?rido bloqueado, de preferencia derivados de ribosa y/o 2-desoxirribosa con una base de nucle?sido protegida, en un solvente anhidro adecuado y en presencia de un catalizador, y eliminar los grupos protectores de dicho compuesto de nucle?sido bloqueado, en donde dicho catalizador se selecciona del grupo que comprende sales de un ?cido sulf?nico alif?tico y/o sales de un ?cido inorg?nico fuerte que contiene un ani?n no nucle?filo.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07019825A EP2048151A1 (en) | 2007-10-10 | 2007-10-10 | Method for producing nucleosides by direct glycosylation of the nucleoside base |
| PCT/EP2008/063582 WO2009047314A2 (en) | 2007-10-10 | 2008-10-10 | Method of producing nucleosides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2010003886A true MX2010003886A (es) | 2010-04-30 |
Family
ID=39485184
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2010003886A MX2010003886A (es) | 2007-10-10 | 2008-10-10 | Metodo para producir nucleosidos. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20100210833A1 (es) |
| EP (2) | EP2048151A1 (es) |
| JP (1) | JP5586468B2 (es) |
| KR (1) | KR101551778B1 (es) |
| CN (1) | CN102119166A (es) |
| AU (1) | AU2008309553B2 (es) |
| BR (1) | BRPI0818249B8 (es) |
| CA (1) | CA2701856C (es) |
| EA (1) | EA017134B1 (es) |
| ES (1) | ES2513241T3 (es) |
| MX (1) | MX2010003886A (es) |
| NZ (1) | NZ584372A (es) |
| WO (1) | WO2009047314A2 (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6887855B2 (en) | 2003-03-17 | 2005-05-03 | Pharmion Corporation | Forms of 5-azacytidine |
| US6943249B2 (en) | 2003-03-17 | 2005-09-13 | Ash Stevens, Inc. | Methods for isolating crystalline Form I of 5-azacytidine |
| HUE055911T2 (hu) * | 2008-05-15 | 2021-12-28 | Celgene Corp | Citidin-analógokat tartalmazó orális készítmények, és eljárások azok alkalmazására |
| EP2318423B1 (en) | 2008-08-08 | 2014-05-07 | ScinoPharm Taiwan, Ltd. | Process for making 5-azacytosine nucleosides and their derivatives |
| JP2012504652A (ja) * | 2008-10-03 | 2012-02-23 | サイノファーム タイワン リミテッド | デシタビンの合成 |
| US8586729B2 (en) | 2008-10-03 | 2013-11-19 | Scinopharm Taiwan Ltd. | Synthesis of decitabine |
| IT1399195B1 (it) | 2010-03-30 | 2013-04-11 | Chemi Spa | Processo per la sintesi di azacitidina e decitabina |
| CN102127135B (zh) * | 2010-12-24 | 2013-12-11 | 中国科学院上海有机化学研究所 | 一种嘧啶类核苷化合物或嘌呤类核苷化合物的制备方法 |
| AU2012236476A1 (en) | 2011-03-31 | 2013-05-02 | Celgene International Sarl | Systhesis of 5-azacytidine |
| WO2013178571A1 (en) * | 2012-05-29 | 2013-12-05 | F. Hoffmann-La Roche Ag | Process for the preparation of 2-deoxy-2-fluoro-2-methyl-d-ribofuranosyl nucleoside compounds |
| CN110028537A (zh) * | 2018-01-11 | 2019-07-19 | 上海百灵医药科技有限公司 | 一种地西他滨的合成方法 |
| CN108299518A (zh) * | 2018-02-02 | 2018-07-20 | 王成宇 | 一种2`-脱氧-β-尿苷的合成方法 |
| CN110128485B (zh) * | 2018-02-09 | 2022-06-07 | 鲁南制药集团股份有限公司 | 一种阿扎胞苷的制备方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2012888C3 (de) * | 1970-03-14 | 1981-04-02 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Verfahren zur Herstellung von 5-Azapyrimidinnucleosiden |
| DE2508312A1 (de) * | 1975-02-24 | 1976-09-02 | Schering Ag | Neues verfahren zur herstellung von nucleosiden |
| DE2757365A1 (de) * | 1977-12-20 | 1979-06-21 | Schering Ag | Neues verfahren zur herstellung von nucleosiden |
| US5426183A (en) * | 1992-06-22 | 1995-06-20 | Eli Lilly And Company | Catalytic stereoselective glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides |
| UA41261C2 (uk) * | 1992-06-22 | 2001-09-17 | Елі Ліллі Енд Компані | Спосіб одержання збагачених бета-аномером нуклеозидів |
| WO1995012593A1 (en) | 1993-11-05 | 1995-05-11 | The Noguchi Institute | 5-0-pyrimidyl-2,3-dideoxy-1-thiofuranoside derivative, process for producing the same, and use thereof |
| IL113432A (en) * | 1994-04-23 | 2000-11-21 | Glaxo Group Ltd | Process for the diastereoselective synthesis of nucleoside analogues |
| JP2001524936A (ja) * | 1996-10-16 | 2001-12-04 | アイ・シー・エヌ・フアーマシユーテイカルズ・インコーポレイテツド | プリンl―ヌクレオシド類およびその用途 |
| ATE282034T1 (de) * | 1998-08-12 | 2004-11-15 | Gilead Sciences Inc | Verfahren zur herstellung von 1,3- oxathiolannukleoside |
| EP2050757A1 (en) * | 2007-10-10 | 2009-04-22 | Cilag AG | Method of producing 2' -deoxy-5-azacytidine (Decitabine) |
-
2007
- 2007-10-10 EP EP07019825A patent/EP2048151A1/en not_active Withdrawn
-
2008
- 2008-10-10 JP JP2010528404A patent/JP5586468B2/ja active Active
- 2008-10-10 CA CA2701856A patent/CA2701856C/en active Active
- 2008-10-10 ES ES08805204.8T patent/ES2513241T3/es active Active
- 2008-10-10 EP EP08805204.8A patent/EP2197892B1/en active Active
- 2008-10-10 KR KR1020107009692A patent/KR101551778B1/ko not_active Expired - Fee Related
- 2008-10-10 US US12/682,325 patent/US20100210833A1/en not_active Abandoned
- 2008-10-10 NZ NZ584372A patent/NZ584372A/en not_active IP Right Cessation
- 2008-10-10 AU AU2008309553A patent/AU2008309553B2/en not_active Ceased
- 2008-10-10 WO PCT/EP2008/063582 patent/WO2009047314A2/en not_active Ceased
- 2008-10-10 EA EA201070438A patent/EA017134B1/ru not_active IP Right Cessation
- 2008-10-10 BR BRPI0818249A patent/BRPI0818249B8/pt not_active IP Right Cessation
- 2008-10-10 MX MX2010003886A patent/MX2010003886A/es active IP Right Grant
- 2008-10-10 CN CN2008801108514A patent/CN102119166A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2008309553B2 (en) | 2013-01-17 |
| WO2009047314A2 (en) | 2009-04-16 |
| KR101551778B1 (ko) | 2015-09-09 |
| JP5586468B2 (ja) | 2014-09-10 |
| CA2701856C (en) | 2016-05-03 |
| WO2009047314A3 (en) | 2012-03-01 |
| NZ584372A (en) | 2011-11-25 |
| US20100210833A1 (en) | 2010-08-19 |
| EP2197892B1 (en) | 2014-07-16 |
| KR20100099104A (ko) | 2010-09-10 |
| EP2197892A2 (en) | 2010-06-23 |
| BRPI0818249A2 (pt) | 2015-04-07 |
| BRPI0818249B8 (pt) | 2021-05-25 |
| AU2008309553A1 (en) | 2009-04-16 |
| EP2048151A1 (en) | 2009-04-15 |
| CA2701856A1 (en) | 2009-04-16 |
| BRPI0818249B1 (pt) | 2021-04-20 |
| ES2513241T3 (es) | 2014-10-24 |
| JP2011526580A (ja) | 2011-10-13 |
| EA017134B1 (ru) | 2012-10-30 |
| EA201070438A1 (ru) | 2011-02-28 |
| CN102119166A (zh) | 2011-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2010003886A (es) | Metodo para producir nucleosidos. | |
| NL300963I9 (nl) | Een verbinding omvattende een gemodificeerd oligonucleotide met een nucleobasensequentie bestaande uit 20 gekoppelde nucleosiden volgens EP-B1-2563920 conclusie 1 (SEQ ID NO: 80), waarbij de gemodificeerde oligonucleotide omvat: een tussenruimtesegment dat bestaat uit tien gekoppelde deoxynucleosiden; een 5' vleugelsegment dat bestaat uit vijf gekoppelde nucleosiden; en een 3' vleugelsegment dat bestaat uit vijf gekoppelde nucleosiden; waarbij het tussenruimtesegment is gepositioneerd tussen het 5' vleugelsegment en het 3' vleugelsegment, waarbij elke nucleoside van elk vleugelsegment een 2'-O-methoxyethylsuiker omvat; waarbij elke cytosine van het gemodificeerde oligonucleotide een 5-methylcytosine is, en waarbij elke internucleosidekoppeling van het gemodificeerde oligonucleotide een fosforothioaatkoppeling is; en in het bijzonder inotersen; en derivaten daarvan, zoals zouten ervan, waaronder natriumzouten, zoals beschermd door EP-B1-2563920. | |
| ES2620131T3 (es) | Nucleótidos marcados | |
| AR082066A2 (es) | Metodo y uso de analogos de nucleosidos fluorados modificados | |
| ES2655916T3 (es) | Aminoglucósidos y usos de los mismos para tratar trastornos genéticos | |
| CA2510477A1 (en) | Process for the preparation of oligonucleotides | |
| WO2007014894A3 (en) | Glucopyranosyl-substituted ( (hetero) cycloalyklethynyl-benzyl) -benzene derivatives and use thereof as sodium-dependent glucose cotransporter (sglt) inhibitors | |
| WO2007121918A3 (en) | Use of 2-(purin-9-yl)-tetrahydofuran-3,4-diol derivatives as adenosine a2a receptor agonists | |
| WO2006015357A3 (en) | 2-propynyl adenosine analogs with modified 5'-ribose groups having a2a agonist activity | |
| Huchting et al. | Synthesis of T‐705‐Ribonucleoside and T‐705‐Ribonucleotide and Studies of Chemical Stability | |
| WO2003068795A1 (en) | Nucleoside analogues and oligonucleotide derivative comprising nucleotide analogue thereof | |
| CA2671306A1 (en) | Process for preparation of 4'-azido cytidine derivatives | |
| WO2007121921A3 (en) | Purine derivatives for use as adenosin a2a receptor agonists | |
| EP0587364A1 (en) | A process for anomerizing nucleosides | |
| NZ593882A (en) | Process for the synthesis of l-fucosyl di- or oligosaccharides and novel 2,3,4 tribenzyl-fucosyl derivatives intermediates thereof | |
| IE883406L (en) | 2',3'-Dideoxy-2'-fluoronucleosides | |
| AU2008309552A1 (en) | Method of producing 2' -deoxy-5-azacytidine (Decitabine) | |
| BRPI0606324A2 (pt) | derivados de purina agindo como agonistas de receptor de a2a | |
| IE33786L (en) | Pyrimidine nucleosides | |
| Hysell et al. | Synthesis and stability of exocyclic triazine nucleosides | |
| Sujino et al. | Stereocontrolled Synthesis of. BETA.-D-2'-Deoxyribonucleosides by Intramolecular Glycosylation. | |
| CA2577449C (en) | Method for the preparation of 2'-deoxy-2',2'-difluorocytidine | |
| IL277066B2 (en) | History of lna-dicarboxylic acid and process for their preparation | |
| DK1071692T3 (da) | Fremgangsmåde til syntese af laminaribiose | |
| AU2003238696A1 (en) | Alkynylpurine compounds and production methods thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |